500 related articles for article (PubMed ID: 19668871)
1. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
[TBL] [Abstract][Full Text] [Related]
2. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
Cases M; Mestres J
Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
4. Databases of protein-protein interactions and their use in drug discovery.
Fuentes G; Oyarzabal J; Rojas AM
Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
[TBL] [Abstract][Full Text] [Related]
5. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
[TBL] [Abstract][Full Text] [Related]
6. Detecting drug targets with minimum side effects in metabolic networks.
Li Z; Wang RS; Zhang XS; Chen L
IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
[TBL] [Abstract][Full Text] [Related]
7. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.
Janga SC; Tzakos A
Mol Biosyst; 2009 Dec; 5(12):1536-48. PubMed ID: 19763339
[TBL] [Abstract][Full Text] [Related]
8. Compound library design for target families.
Balakin KV; Ivanenkov YA; Savchuk NP
Methods Mol Biol; 2009; 575():21-46. PubMed ID: 19727610
[TBL] [Abstract][Full Text] [Related]
9. Interaction networks: from protein functions to drug discovery. A review.
Chautard E; Thierry-Mieg N; Ricard-Blum S
Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972
[TBL] [Abstract][Full Text] [Related]
10. Predicting druggable binding sites at the protein-protein interface.
Fuller JC; Burgoyne NJ; Jackson RM
Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
[TBL] [Abstract][Full Text] [Related]
11. Drug-target network.
Yildirim MA; Goh KI; Cusick ME; Barabási AL; Vidal M
Nat Biotechnol; 2007 Oct; 25(10):1119-26. PubMed ID: 17921997
[TBL] [Abstract][Full Text] [Related]
12. Drug-target interaction prediction by random walk on the heterogeneous network.
Chen X; Liu MX; Yan GY
Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
[TBL] [Abstract][Full Text] [Related]
13. Drugging challenging targets using fragment-based approaches.
Coyne AG; Scott DE; Abell C
Curr Opin Chem Biol; 2010 Jun; 14(3):299-307. PubMed ID: 20223699
[TBL] [Abstract][Full Text] [Related]
14. Ligand and decoy sets for docking to G protein-coupled receptors.
Gatica EA; Cavasotto CN
J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
[TBL] [Abstract][Full Text] [Related]
15. Extracting sets of chemical substructures and protein domains governing drug-target interactions.
Yamanishi Y; Pauwels E; Saigo H; Stoven V
J Chem Inf Model; 2011 May; 51(5):1183-94. PubMed ID: 21506615
[TBL] [Abstract][Full Text] [Related]
16. [Prediction of network drug target based on improved model of bipartite graph valuation].
Liu X; Lu P; Zuo X; Chen J; Yang H; Yang Y; Gao Y
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):125-9. PubMed ID: 22737836
[TBL] [Abstract][Full Text] [Related]
17. Network-based characterization of drug-regulated genes, drug targets, and toxicity.
Kotlyar M; Fortney K; Jurisica I
Methods; 2012 Aug; 57(4):499-507. PubMed ID: 22749929
[TBL] [Abstract][Full Text] [Related]
18. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
Bieler M; Heilker R; Köppen H; Schneider G
J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential HIV-1 targets of minocycline.
Jenwitheesuk E; Samudrala R
Bioinformatics; 2007 Oct; 23(20):2797-9. PubMed ID: 17804437
[TBL] [Abstract][Full Text] [Related]
20. iDrug-Target: predicting the interactions between drug compounds and target proteins in cellular networking via benchmark dataset optimization approach.
Xiao X; Min JL; Lin WZ; Liu Z; Cheng X; Chou KC
J Biomol Struct Dyn; 2015; 33(10):2221-33. PubMed ID: 25513722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
